Zymeworks Inc. (ZYME) |
|
24 0.12 (0.5%)
|
07-16 16:02 |
|
Open: |
23.95 |
Pre. Close: |
23.88 |
|
High:
|
24.39 |
Low:
|
23.32 |
|
Volume:
|
296,065 |
Market Cap:
|
948M |
|
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
24.489 - 24.642 |
24.642 - 24.75 |
|
Low:
|
23.181 - 23.37 |
23.37 - 23.503 |
|
Close:
|
23.631 - 23.909 |
23.909 - 24.104 |
|
Technical analysis |
as of: 2019-07-16 3:25:13 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 29.78 One year: 34.79 |
| Support: |
Support1: 20.62 Support2: 17.60 |
| Resistance: |
Resistance1: 25.50 Resistance2: 29.78 |
| Pivot: |
23.44 |
| Moving Average: |
MA(5): 24.01  MA(20): 22.68
MA(100): 18.20 MA(250): 15.71 |
| MACD: |
MACD(12,26): 1.15 Signal(9): 1.17 |
| Stochastic oscillator: |
%K(14,3): 67.06 %D(3): 71.81 |
| RSI: |
RSI(14): 65.95 |
| 52-week: |
High: 25.50 Low: 10.72 Change(%): 63.6 |
| Average Vol(K): |
3-Month: 29225 10-Days: 34537 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.ZYME has closed below upper band by 30.5%. Bollinger Bands are 15.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Fri, 28 Jun 2019 05:10:52 Z
Red Hot Stocks Ahead of G20 Summit
Wed, 26 Jun 2019 12:09:36 Z
Will Zymeworks Continue to Surge Higher?
Wed, 07 Nov 2018 02:54:58 Z
Zymeworks Inc. (ZYME) Reports Q3 Loss, Tops Revenue Estimates
Fri, 28 Apr 2017 14:28:17 Z
Zymeworks prices IPO at $13, the low end of the range
Mon, 17 Apr 2017 15:55:53 Z
Cancer biotech Zymeworks sets terms for $65 million IPO
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
32.06 |
| Shares Float (M) |
25.15 |
|
% Held by Insiders
|
17.60 |
|
% Held by Institutions
|
40.19 |
|
Shares Short (K)
|
385 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-0.950 |
|
EPS Est. Current Year
|
-2.980 |
|
EPS Est. Next Year
|
-2.540 |
|
EPS Est. Next Quarter
|
-0.670 |
|
Forward EPS
|
-2.309 |
|
Book Value (p.s.)
|
5.300 |
|
PEG Ratio
|
|
|
Profit Margin
|
-44.67 |
|
Operating Margin
|
-42.60 |
|
Return on Assets (ttm)
|
-9.8 |
|
Return on Equity (ttm)
|
-21.9 |
|
Qtrly Rev. Growth
|
29712.5 |
|
Gross Profit (p.s.)
|
-0.114 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-0.790 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
20.45 |
|
Levered Free Cash Flow (M)
|
0.77 |
Stock Valuations |
|
P/E
|
-25.37 |
|
P/E Growth Ratio
|
0.01 |
|
P/BV
|
4.55 |
|
P/S
|
366182944.00 |
|
P/CF
|
37.78 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
